학술논문
Phase I Study Combining Ibrutinib with Rituximab, Ifosfamide, Carboplatin, and Etoposide (R-ICE) in Patients with Relapsed or Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL): NCI-Cancer Therapeutics Evaluation Program (CTEP) #9588
Document Type
Abstract
Author
Source
In Blood 2 December 2016 128(22):4198-4198
Subject
Language
ISSN
0006-4971